Refreshing results…
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
Download from doi.orgEULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
UploadRisk of malignancy in patients treated for systemic necrotising vasculitis
UploadMissing publications? Search for publications with a matching author name.